These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32201901)

  • 41. Disutility in Patients with Hidradenitis Suppurativa: A Cross-sectional Study Using EuroQoL-5D.
    Riis PT; Vinding GR; Ring HC; Jemec GB
    Acta Derm Venereol; 2016 Feb; 96(2):222-6. PubMed ID: 25940640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners.
    Cuenca-Barrales C; Montero-Vilchez T; Krajewski PK; Szepietowski JC; Matusiak L; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of Life of Patients With Pyoderma Gangrenosum and Hidradenitis Suppurativa.
    Gerard AJ; Feldman SR; Strowd L
    J Cutan Med Surg; 2015; 19(4):391-6. PubMed ID: 25775617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool.
    Guart JA; Byers VV; Sasson DC; Bassiri-Tehrani B; Ranzer M; Purnell C
    Cureus; 2021 Feb; 13(2):e13172. PubMed ID: 33575157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
    Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.
    Kirsten N; Zander N; Augustin M
    Arch Dermatol Res; 2021 Mar; 313(2):95-99. PubMed ID: 32322958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The psychosocial impact of hidradenitis suppurativa.
    Gooderham M; Papp K
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S19-22. PubMed ID: 26470609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The differentiating effect of COVID-19-associated stress on the morbidity of blood donors with symptoms of hidradenitis suppurativa, hyperhidrosis, or psoriasis.
    Henning MAS; Didriksen M; Ibler KS; Ostrowski SR; Erikstrup C; Nielsen K; Sækmose SG; Hansen TF; Ullum H; Thørner LW; Kaspersen KA; Mikkelsen S; Jemec GBE; Pedersen OB
    Qual Life Res; 2023 Oct; 32(10):2925-2937. PubMed ID: 37270451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting quality of life in patients with hidradenitis suppurativa.
    Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
    Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study.
    Cuenca-Barrales C; Molina-Leyva A
    Dermatology; 2020; 236(1):37-45. PubMed ID: 31434072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of Hidradenitis Suppurativa Comorbidities Over Time: A Prospective Cohort Study of Danish Blood Donors.
    Andersen RK; Loft IC; Burgdorf K; Erikstrup C; Pedersen OB; Jemec GBE
    Acta Derm Venereol; 2021 Jan; 101(1):adv00376. PubMed ID: 33372684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pain and Late-Onset of Hidradenitis Suppurativa Can Have a Negative Influence on Occupational Status and Educational Level. A Cross-Sectional Study.
    Barboza-Guadagnini L; Podlipnik S; Fuertes I; Morgado-Carrasco D; Bassas-Vila J
    Actas Dermosifiliogr; 2023 Jan; 114(1):1-8. PubMed ID: 36030826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.
    Tampouratzi E; Kanni T; Katsantonis J; Douvali T
    F1000Res; 2019; 8():2002. PubMed ID: 33456757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alexithymia, Psychological Distress, and Social Impairment in Patients with Hidradenitis Suppurativa.
    Quinto RM; Sampogna F; Fania L; Ciccone D; Fusari R; Mastroeni S; Iani L; Abeni D
    Dermatology; 2021; 237(1):103-110. PubMed ID: 31743903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina.
    Zimman S; Comparatore MV; Vulcano AF; Absi ML; Mazzuoccolo LD
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):297-302. PubMed ID: 30885385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Weight counseling in pediatric hidradenitis suppurativa patients.
    Reichert B; Fernandez Faith E; Harfmann K
    Pediatr Dermatol; 2020 May; 37(3):480-483. PubMed ID: 32124482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study.
    Alavi A; Anooshirvani N; Kim WB; Coutts P; Sibbald RG
    Am J Clin Dermatol; 2015 Feb; 16(1):61-5. PubMed ID: 25432664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.